Risks of AI in Life Sciences

Risks of AI in Life Sciences: Building, Buying and Balancing Control. MIGx AG. Roman Dushko.

Basel, Switzerland – October 28, 2025 –
In Life Sciences, adopting AI brings new questions of control and accountability. This blog explores the practical risks of building versus buying AI systems, and how governance, validation, and supplier oversight keep innovation compliant and under control.

Building a Security Strategy for Life Sciences

Building a Security Strategy in Life Sciences MIGx Roman Dushko

Basel, Switzerland – October 13, 2025 –
A security strategy only works when it shapes daily choices. In Life Sciences, it has to connect risk, frameworks, and lifecycle so that protection, compliance, and innovation move together. This blog looks at how to build strategies that stay active instead of gathering dust.